Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BioDelivery Sciences International stock

Own BioDelivery Sciences International stock in just a few minutes.

BioDelivery Sciences International, Inc is a biotechnology business based in the US. BioDelivery Sciences International shares (BDSI) are listed on the NASDAQ and all prices are listed in US Dollars. BioDelivery Sciences International employs 176 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BioDelivery Sciences International

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BDSI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BioDelivery Sciences International share price

Use our graph to track the performance of BDSI stocks over time.

BioDelivery Sciences International shares at a glance

Information last updated 2021-04-30.
52-week range$3.04 - $5.45
50-day moving average $3.63
200-day moving average $3.93
Wall St. target price$7.08
PE ratio 14.625
Dividend yield N/A (0%)
Earnings per share (TTM) $0.24

Buy BioDelivery Sciences International shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioDelivery Sciences International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is BioDelivery Sciences International under- or over-valued?

Valuing BioDelivery Sciences International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioDelivery Sciences International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

BioDelivery Sciences International's P/E ratio

BioDelivery Sciences International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, BioDelivery Sciences International shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

BioDelivery Sciences International's PEG ratio

BioDelivery Sciences International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioDelivery Sciences International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

BioDelivery Sciences International's EBITDA

BioDelivery Sciences International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $45.6 million.

The EBITDA is a measure of a BioDelivery Sciences International's overall financial performance and is widely used to measure a its profitability.

BioDelivery Sciences International financials

Revenue TTM $156.5 million
Operating margin TTM 24.37%
Gross profit TTM $131.8 million
Return on assets TTM 11.27%
Return on equity TTM 28.89%
Profit margin 16.43%
Book value $1.07
Market capitalisation $354 million

TTM: trailing 12 months

Shorting BioDelivery Sciences International shares

There are currently 3.9 million BioDelivery Sciences International shares held short by investors – that's known as BioDelivery Sciences International's "short interest". This figure is 0.2% down from 3.9 million last month.

There are a few different ways that this level of interest in shorting BioDelivery Sciences International shares can be evaluated.

BioDelivery Sciences International's "short interest ratio" (SIR)

BioDelivery Sciences International's "short interest ratio" (SIR) is the quantity of BioDelivery Sciences International shares currently shorted divided by the average quantity of BioDelivery Sciences International shares traded daily (recently around 1.3 million). BioDelivery Sciences International's SIR currently stands at 2.98. In other words for every 100,000 BioDelivery Sciences International shares traded daily on the market, roughly 2980 shares are currently held short.

However BioDelivery Sciences International's short interest can also be evaluated against the total number of BioDelivery Sciences International shares, or, against the total number of tradable BioDelivery Sciences International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioDelivery Sciences International's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 BioDelivery Sciences International shares in existence, roughly 40 shares are currently held short) or 0.0426% of the tradable shares (for every 100,000 tradable BioDelivery Sciences International shares, roughly 43 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BioDelivery Sciences International.

Find out more about how you can short BioDelivery Sciences International stock.

BioDelivery Sciences International share dividends

We're not expecting BioDelivery Sciences International to pay a dividend over the next 12 months.

BioDelivery Sciences International share price volatility

Over the last 12 months, BioDelivery Sciences International's shares have ranged in value from as little as $3.04 up to $5.45. A popular way to gauge a stock's volatility is its "beta".

BDSI.US volatility(beta: 0.76)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioDelivery Sciences International's is 0.759. This would suggest that BioDelivery Sciences International's shares are less volatile than average (for this exchange).

BioDelivery Sciences International overview

BioDelivery Sciences International, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.

Frequently asked questions

What percentage of BioDelivery Sciences International is owned by insiders or institutions?
Currently 2.495% of BioDelivery Sciences International shares are held by insiders and 76.801% by institutions.
How many people work for BioDelivery Sciences International?
Latest data suggests 176 work at BioDelivery Sciences International.
When does the fiscal year end for BioDelivery Sciences International?
BioDelivery Sciences International's fiscal year ends in December.
Where is BioDelivery Sciences International based?
BioDelivery Sciences International's address is: 4131 ParkLake Avenue, Raleigh, NC, United States, 27612
What is BioDelivery Sciences International's ISIN number?
BioDelivery Sciences International's international securities identification number is: US09060J1060
What is BioDelivery Sciences International's CUSIP number?
BioDelivery Sciences International's Committee on Uniform Securities Identification Procedures number is: 09060J106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site